ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,249,770 | +11.3% | 119,741 | +26.0% | 0.04% | +15.6% |
| Q2 2023 | $2,920,916 | -18.3% | 95,020 | -4.2% | 0.03% | -20.0% |
| Q1 2023 | $3,573,063 | -2.8% | 99,169 | +6.6% | 0.04% | -4.8% |
| Q4 2022 | $3,675,166 | -0.0% | 92,995 | +1.7% | 0.04% | -6.7% |
| Q3 2022 | $3,676,000 | -2.6% | 91,429 | +1.9% | 0.04% | +2.3% |
| Q2 2022 | $3,774,000 | +19.5% | 89,712 | +10.7% | 0.04% | +33.3% |
| Q1 2022 | $3,157,000 | -5.5% | 81,049 | -3.3% | 0.03% | 0.0% |
| Q4 2021 | $3,340,000 | – | 83,850 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |